A signature for immune response correlates with HCV treatment outcome in Caucasian subjects

This data article contains Supplementary material for a published research article describing a whole-blood proteomic signature that predicts treatment outcome for subjects infected with hepatitis C virus (HCV) [1]. The proteomic signature is derived from whole-blood samples from subjects infected w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hare, Brian J., Haseltine, Eric, Fleming, Mark, Chelsky, Daniel, McIntosh, Laura, Allard, Rene, Botfield, Martyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510051/
https://www.ncbi.nlm.nih.gov/pubmed/26217718
http://dx.doi.org/10.1016/j.dib.2015.01.009
_version_ 1782382110296768512
author Hare, Brian J.
Haseltine, Eric
Fleming, Mark
Chelsky, Daniel
McIntosh, Laura
Allard, Rene
Botfield, Martyn
author_facet Hare, Brian J.
Haseltine, Eric
Fleming, Mark
Chelsky, Daniel
McIntosh, Laura
Allard, Rene
Botfield, Martyn
author_sort Hare, Brian J.
collection PubMed
description This data article contains Supplementary material for a published research article describing a whole-blood proteomic signature that predicts treatment outcome for subjects infected with hepatitis C virus (HCV) [1]. The proteomic signature is derived from whole-blood samples from subjects infected with HCV. The article includes detailed experimental and computational methods used in the analysis. The article also includes tables of demographic and other information about the subjects. Finally, the article includes several figures and tables showing detailed results of the analyses (e.g. lists of identified proteins and coefficients/ROC curves for the regression models).
format Online
Article
Text
id pubmed-4510051
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-45100512015-07-27 A signature for immune response correlates with HCV treatment outcome in Caucasian subjects Hare, Brian J. Haseltine, Eric Fleming, Mark Chelsky, Daniel McIntosh, Laura Allard, Rene Botfield, Martyn Data Brief Data Article This data article contains Supplementary material for a published research article describing a whole-blood proteomic signature that predicts treatment outcome for subjects infected with hepatitis C virus (HCV) [1]. The proteomic signature is derived from whole-blood samples from subjects infected with HCV. The article includes detailed experimental and computational methods used in the analysis. The article also includes tables of demographic and other information about the subjects. Finally, the article includes several figures and tables showing detailed results of the analyses (e.g. lists of identified proteins and coefficients/ROC curves for the regression models). Elsevier 2015-02-11 /pmc/articles/PMC4510051/ /pubmed/26217718 http://dx.doi.org/10.1016/j.dib.2015.01.009 Text en © 2015 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Data Article
Hare, Brian J.
Haseltine, Eric
Fleming, Mark
Chelsky, Daniel
McIntosh, Laura
Allard, Rene
Botfield, Martyn
A signature for immune response correlates with HCV treatment outcome in Caucasian subjects
title A signature for immune response correlates with HCV treatment outcome in Caucasian subjects
title_full A signature for immune response correlates with HCV treatment outcome in Caucasian subjects
title_fullStr A signature for immune response correlates with HCV treatment outcome in Caucasian subjects
title_full_unstemmed A signature for immune response correlates with HCV treatment outcome in Caucasian subjects
title_short A signature for immune response correlates with HCV treatment outcome in Caucasian subjects
title_sort signature for immune response correlates with hcv treatment outcome in caucasian subjects
topic Data Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510051/
https://www.ncbi.nlm.nih.gov/pubmed/26217718
http://dx.doi.org/10.1016/j.dib.2015.01.009
work_keys_str_mv AT harebrianj asignatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT haseltineeric asignatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT flemingmark asignatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT chelskydaniel asignatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT mcintoshlaura asignatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT allardrene asignatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT botfieldmartyn asignatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT harebrianj signatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT haseltineeric signatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT flemingmark signatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT chelskydaniel signatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT mcintoshlaura signatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT allardrene signatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects
AT botfieldmartyn signatureforimmuneresponsecorrelateswithhcvtreatmentoutcomeincaucasiansubjects

Ejemplares similares